«
»

MedImmune receives FDA approval for FluMist Quadrivalent vaccine

Via Scoop.it – Virology News

FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration.

Via www.news-medical.net

This entry was posted on 27 March, 2012 at 19:39 and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a comment